Posts tagged with "Centers for Disease Control and Prevention"

Meduza illustration by Heather Skovlund for 360 Magazine

Meduza × Museum Fiasco

Electronic Group, Meduza, to Release Single as Audio-Visual Immersive Experience in Partnership with Playmodes Studio at Museum Fiasco in Las Vegas

Single Debut will be First Major Music Launch at a Contemporary Museum

Electronic music artists, Meduza, in collaboration with Playmodes Studio and Insomniac Records, will release an immersive song launch and experience as the first music launch in a contemporary museum at Museum Fiasco, located inside AREA15 at 3215 S. Rancho Dr. The award-wining trio will be on-site for the launch event starting at 10 p.m. on Friday, May 14.

The track, titled “Headrush,” will play in sync with a lightshow produced by Playmodes Studio, the group behind the concept and audiovisual contents of Museum Fiasco’s current Cluster exhibitions, “Kernel,” “Railwave” and “Stellar.” The “Headrush” experience will play from 10 p.m. – midnight from Friday, May 14 through Sunday, May 30. “The debut of this incredible track from Meduza will serve as the first time a single has been released in a contemporary art museum as part of its launch,” said Ryan Doherty, museum curator.

Grammy 2020 nominees for “Best Dance Music Recording,” for their 2019 release ‘Piece of your Heart’, Meduza has spent the last two years leading the charge in returning house music to daytime radio. Meduza is the “Most Listened to” Italian artist on Apple Music and Spotify in history and the fastest growing Italian artists on YouTube, with over one million subscribers. Their debut release, “Piece of Your Heart,” featuring Goodboys, has over two billion streams globally, reaching the top 10 charts in more than 20 countries. In late 2020, Meduza released their third single “Paradise,” featuring Dermot Kennedy, which has accumulated over 500 million streams. The track entered the “Global Top 50” playlist on Spotify and has remained there for 15 weeks straight.

“We’re thrilled to have Meduza and Playmodes collaborate to make music and art accessible and interchangeable at Museum Fiasco,” said Doherty. “The music interacting with the sound and light features creates an unforgettable experience, and we can’t wait to welcome the public to this unprecedented show.”

“As techno music lovers, we feel inspired by the rhythms and sounds of Meduza’s new song, “Headrush,” said Eloi Maduell and Santi Villanova, founders of Playmodes Studio. “It is visual and emotive music which will shine at its best with the perfect companion of light, and we’re passionate to premiere this new experience for the Museum Fiasco and AREA15 audience.”

Museum Fiasco is located on the mezzanine of AREA15, the new immersive art, event and entertainment district. Conceptualized and designed by Doherty, the 5,000-square-foot gallery showcases futuristic exhibits, audio-visual experiences and immersive mixed media in a space that fosters a sense of connectivity.

Museum Fiasco is open Monday to Thursday from 3 p.m. to 10 p.m., Friday from 3 p.m. to midnight, Saturday from 10 a.m. to midnight, and Sunday from 10 a.m. to 10 p.m. Advance reservations are highly encouraged. Tickets for the “Headrush” experience are available at Museum Fiasco. More information is available on the website, and on FacebookInstagram and Twitter.

Located in the heart of Las Vegas and minutes from the Strip, AREA15 offers immersive activations, monumental art installations, socially distanced events, extraordinary design elements, unique retail, groundbreaking technology, bars, eateries and much more. The complex also offers nearly 40,000 square feet of indoor and outdoor event space.

AREA15 follows the latest recommendations of leading health experts and government authorities, including the World Health Organization and Centers for Disease Control and Prevention. And true to the insatiable hunger for all things inventive and groundbreaking, AREA15 is using cutting-edge, state-of-the-art technology to help implement these recommendations, including an AI-driven thermal scanning platform that screens temperature accurately and non-invasively, detects the absence of a mask, and alerts staff when social distancing thresholds are not being met. 

Mosquito illustration by Heather Skovlund for 360 Magazine

Mosquito Season

How to Prepare for Mosquito Season

Mosquito season is right around the corner. If you happen to live in warmer regions of the country, you might already be seeing some mosquito activity around your home. Even if it will be a couple of months until the warm weather reaches your part of the country, it is very important to prepare for mosquito season early.

Here is why you should begin to prepare for mosquito season early and some ways to do that:

Why should I prepare for mosquito season early?

  • Mosquitoes may already be in your yard: While they seem to disappear in the colder months of the year, some mosquitoes can in fact survive the winter. How? Through a process called overwintering. Overwintering is when female mosquitoes lay their eggs before winter, and the eggs survive and eventually hatch when temperatures rise again.
  • Being prepared means avoiding unnecessary hassle: Why wait until your yard is filled with mosquitoes to do something about them? By preparing early, you can lessen the stress of mosquito season and focus on enjoying your outdoor space.

How should I prepare for mosquito season?

There are a number of ways you can get ready for the beginning of mosquito season and help prevent bites around your home. Below are a few:

  • Hire your local mosquito control company: The best way to beat mosquitoes is to enlist the help of a professional. Our specialists at Mosquito Authority are committed to doing everything possible to ensure your home and yard are mosquito-free zones. Our treatments are even designed to break up the 21-day lifecycle of mosquitoes, which means you won’t be bothered in between treatments.
  • Be aware of the best mosquito repellents and how to use them: Although your home will be mosquito-free after your Mosquito Authority treatments, other outdoor areas might not be. If you are planning on hiking, going to the park, or participating in any other outdoor activities in the spring and summer, make sure to apply insect repellent. The Centers for Disease Control and Prevention recommend using products that contain DEET, picaridin, oil of lemon eucalyptus, or other EPA-registered products.
  • Make sure your yard isn’t a breeding ground for mosquitoes: Mosquitoes need water to lay eggs, which is why any areas of standing water make for popular mosquito breeding grounds. As the snow begins to melt (or you start to experience more rainfall), standing water will start building up around your yard. A big part of DIY mosquito control is getting rid of standing water near your home; this includes tipping over items like trash can lids, tire swings, and children’s toys to empty the water out.

Joe Malinowski is the director of pest management for Mosquito Authority and Pest Authority. He has worked on the operational and corporate side of top companies in the pest control industry. Malinowski served as vice president of technical services at Orkin and vice president of sales for B&G Equipment Company. He also helped launch new and innovative products in the industry for ForeFront Product Design and SenesTech. Operational roles at the branch, regional, and divisional levels have given him an understanding of profit and loss, customer and employee retention, correct product and equipment selection, and precise training to ensure exceptional service.

Le Parc Suites

Le Parc Suite Hotel

Le Parc Suite Hotel is the perfect, newly renovated spot to safely begin your travels with. Inspired by its location in West Hollywood, Le Parc Suite Hotel’s modern redesign features a curated collection of locally inspired original artwork and a sophisticated architectural palette.

“We are thrilled to introduce the new Le Parc Suite Hotel in our dynamic city of West Hollywood,” said Bert Seneca, general manager of Le Parc Suite Hotel. “Our revitalized hotel is designed as a place for everyone, as reflected in our diverse artwork, inviting amenities and exceptional service. We’re proud to welcome guests to Le Parc Suites where they’ll experience the energy of West Hollywood combined with the comforts of home.”

Le Parc’s Peace of Mind Promise adheres to all Safe Stay Guidelines put in place by the American Hotel & Lodging Association, which are based on guidance and direct feedback from the CDC. Le Parc is an ideal destination for a safe retreat with individual HVAC units in each suite for fresh air, kitchenettes for dining in, staircases as alternatives to elevators and uncrowded public spaces.

Drawing influence from its West Hollywood location, Le Parc features brilliantly curated original artwork throughout the hotel including a Charlie Edmiston mural, Scott Hile “LOVE” mural, pop culture portraits by Srinjoy Gangopadhyay, and Craig Alan paintings.

The renovations also include a modern fitness center and rooftop pool. Le Parc has built a brand-new, state-of-the-art fitness center with equipment for cardio, weightlifting, resistance training, yoga and stretching. The fitness center also offers a complimentary Peloton available to guests on a first-come basis.

In celebration of the redesign, Le Parc has created a special offer, called “The Ultimate Threesome,” combining you, plus one huge suite, plus free overnight parking. Travelers can save with this offer as they enjoy delicious cuisine from Le Parc’s restaurant, Knoll, relax on the Skydeck, and feel safe with the Peace of Mind Promise.

Follow Le Parc Suite Hotel: Website | Facebook | Instagram

Covid and health illustration

PFCD × Antimicrobial Resistance

The Partnership to Fight Chronic Disease (PFCD) today announced a new initiative to advance awareness on the growing problem of antimicrobial resistance (AMR, aka “superbugs”) and to drive action for policy changes to address the threat AMR poses to our health.

According to the Centers for Disease Control and Prevention (CDC), more than 2.8 million drug-resistant infections occur in the U.S. each year and more than 35,000 people die as a result. The COVID-19 crisis has increased public awareness on the importance of having the right treatments available to treat public health crises as they arise. The threat of AMR looms large as an existing and growing public health need.

In addition to educating and drawing attention to AMR as a pressing public health issue, the Partnership to Fight Infectious Disease (PFID) will:

* Advocate for policy changes to encourage research and development of new treatments and therapies for infectious diseases, * Motivate broad change in the way antimicrobial treatments (e.g. antibiotics, antifungals) are developed, distributed, and consumed, and * Reinforce awareness about the value of antimicrobial treatments, the impact to the practice of modern medicine, and the threat to individual health.

“The launch of PFID is an extension of PFCD’s work for over a decade to advance a vision for a healthier future. The significant impact of the current COVID-19 pandemic on the millions of Americans living with one or more chronic conditions is a long-overdue wake-up call that demands an answer,” stated PFCD Chairman Ken Thorpe. “PFCD stands committed to our goals of addressing the burden of chronic disease, motivating calls for change, and challenging policymakers to create sustainable progress for both chronic and infectious disease threats that exact a heavy human and economic toll in America.”

According to a recent national poll of 1,000 likely voters, there is considerable urgency around and support of policy changes on issues related to AMR.

“The level of concern voters have about antimicrobial resistance is intense and remarkably consistent across the country,” said Celinda Lake, President of Lake Research Partners. “They want this issue to be a high priority for policymakers.”

When presented with some background on AMR, 85 percent of respondents said they were very or somewhat concerned about the issue and 76 percent believe that the development of new antibiotics should be a top or high priority.

More than 50 percent of respondents strongly agree that the government, universities, and drug companies need to all work together to deal with antimicrobial resistance. The strongest predictor of concern for this issue is if a voter has been impacted by COVID-19.

Fifty-nine percent of those who have been seriously impacted by COVID-19 are much more likely to say they are very concerned about AMR, and are also more likely to feel the development of new antibiotics should be a top or high priority (87%) compared to those who haven’t been seriously impacted (64%).

Levels of concern were notably higher among people of color and older Americans, those most impacted by the current pandemic. Further, supporting a candidate who makes the development of new antibiotics a priority was a likelihood for many, and a strong majority believe investment in antibiotics is too low.

“Everyone needs antibiotics to work, whether you are living with chronic disease, are having a routine surgery or undergoing cancer treatment or dialysis. Antibiotics are the safety net of modern medicine, and every procedure becomes more dangerous if we lose them,” said Kevin Outterson, Executive Director of CARB-X, a global non-profit partnership that funds the early development of new antibiotics, vaccines, and rapid diagnostics urgently need to treat superbugs. “There are solutions. We need to invest in new antibiotics to address drug-resistant pathogens.”

While the causes for the existing shortfall are many, the PFID initiative will prioritize prevention and translate knowledge into action by stakeholders across the health care continuum – patients, providers, employers, policymakers, payers, pharmaceutical companies, and many others. In doing so, the end goal is to cultivate collaboration among both public and private stakeholders to expand education and awareness of the issues and related impact areas, and to encourage and support innovation and development of quality treatments and therapies that can address the health threats of today and protect patients at large into the future.

“Without effective antibiotics many of the advances of modern medicine are in jeopardy. We must curtail the overuse and misuse of antibiotics that is driving the development of resistance and invest in new antibiotics that can treat superbugs. IDSA welcomes the PFID partnership to help drive the policy changes we need,” stated Amanda Jezek, Senior Vice President, Public Policy and Government Relations, Infectious Diseases Society of America.

For more information about the PFID and efforts to address AMR throughout the U.S. and across the globe, click HERE.

The Partnership to Fight Chronic Disease (PFCD) is an international coalition of hundreds of patient, provider, community, business, and labor groups, and health policy experts, committed to raising awareness of the number one cause of death, disability and rising health care costs: chronic disease.

Rapidly detecting invisible dangers to food

When food is recalled due to contamination from bacteria such as salmonella, one may wonder how a tainted product ended up on store shelves. New technology being developed at the University of Missouri could give retailers and regulators an earlier warning on dangers in food, improving public health and giving consumers peace of mind.

The biosensor provides a rapid way for producers to know if this invisible danger is present in both raw and ready-to-eat food before it reaches the store. Annually, more than 48 million people get sick from foodborne illnesses in America, such as salmonella, according to the Centers for Disease Control and Prevention.

“Current tests used to determine positive cases of salmonella — for instance culturing samples and extracting DNA to detect pathogens — are accurate but may take anywhere from one to five days to produce results,” said Mahmoud Almasri, associate professor of electrical engineering and computer science at the MU College of Engineering. “With this new device, we can produce results in just a few hours.”

In this study, researchers focused on poultry products, such as chicken and turkey. The biosensor uses a specific fluid that is mixed with the food to detect the presence of bacteria, such as salmonella, along a food production line in both raw and ready-to-eat food. That way, producers can know within a few hours — typically the length of a worker’s shift — if their products are safe to send out for sale to consumers. The researchers believe their device will enhance a food production plant’s operational efficiency and decrease cost.

“Raw and processed food could potentially contain various levels of bacteria,” said Shuping Zhang, professor and director of the Veterinary Medical Diagnostic Laboratory at the MU College of Veterinary Medicine. “Our device will help control and verify that food products are safe for consumers to eat and hopefully decrease the amount of food recalls that happen.”

Researchers said the next step would be testing the biosensor in a commercial setting. Almasri said he believes people in the food processing industry would welcome this device to help make food safer.

The study, “A microfluidic based biosensor for rapid detection of Salmonella in food products,” was published in PLOS ONE, one of the world’s leading peer-reviewed journals focused on science and medicine. Other authors include Ibrahem Jasim, Zhenyu Shen, Lu Zhao at MU; and Majed Dweik at Lincoln University. Funding was provided by a partnership between MU, the Coulter Foundation and the U.S. Department of Agriculture. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.

This study details the latest findings for this interdisciplinary team of researchers who have developed multiple biosensors and published results of their previous findings in Scientific Reports, Biosensors and Bioelectronics and Electrophoresis.

National Drink Wine Day

Cheers! Celebrate National Drink Wine Day by Helping Your Heart, Gut, and Brain

Rosé Piscine, a rosé wine specifically made to drink over ice, serves up some of the health benefits the drink offers
February 18th is National Drink Wine Day, which is a day each year that celebrates the love and health benefits associated with wine. According to the consulting group BW 166, wine sales in the U.S. topped $72.2 billion in 2018, which was nearly a 5 percent increase over the prior year. Clearly, we are nation that loves a good glass of wine, and the more we learn of the health benefits, the more likely more of us will add a bottle to our grocery list.
“People were enjoying a good glass of wine long before the research showed that there are health benefits,” explains Ken Lang, managing partner at Rosé Piscine, a rosé wine specifically made to drink over ice. “Now we can enjoy our glass of wine and feel good about what it is doing for our body, too. Rarely do we find something that we enjoy so much that also provides health benefits.”
Wine enthusiasts can rejoice as they celebrate National Drink Wine Day this year, because the drink has plenty of research pointing to the fact that it’s a healthy beverage to drink in moderation. What exactly is moderation? According to the Centers for Disease Control and Prevention (CDC), moderate drinking is up to one drink per day for women and two drinks per day for men. One drink is defined as being four ounces of wine. Further, they recommend that number is not the average consumed over a week, but the amount consumed on any given day.
Most people who enjoy having a glass of wine with their meal love the taste, but they may not be aware of the way it’s helping their body. Here are some of the many health benefits that have been associated with making wine a part of your diet:

  • Heart health The National Institutes of Health reports that studies have shown that adults who drink light to moderate amounts of alcohol may be less likely to develop heart disease than those who do not drink at all or are heavy drinkers.
  • Gut health The April 2017 issue of the journal Current Opinion in Biotechnology included the research results of a study on the health benefits of fermented foods, including wine. The study found that fermented foods, including wine, provide health benefits well beyond the starting food materials, and contain living microorganisms of which some are genetically similar to strains used as probiotics.
  • Diabetes health The April 2017 issue of the journal Endocrine reports that the American Diabetes Association and the American Heart Association recommend a Mediterranean diet for improving glycemic control and cardiovascular risk factors in type 2 diabetes. It also reports that studies show that higher adherence to the Mediterranean diet is associated with a 20-23 % reduced risk of developing type 2 diabetes. The Mediterranean diet is one that includes drinking wine in moderation.
  • Brain health Research out of the University of Rochester Medical Center in 2018 found that drinking wine in moderation was associated with reducing inflammation and helping the brain to clear away toxins, including those that are associated with Alzheimer’s disease.

“From the brain to gut to your heart, drinking a little wine has health benefits for most people,” added Helppie. “It’s nice to feel good about what you are drinking, whether with dinner, at a party, or at the beach. You can drink some wine and know you are doing your body good.”
Rosé Piscine, a wine that has sold millions of bottles in France and Brazil, recently became available for sale in the United States. Uniquely, it is a wine that has been created to be served over ice. Rosé Piscine is made by Pascal Nacenta in southwest France. The French rosé is 100 percent destemmed, fermented for 20 days with cold stabilization at 60 degrees and then filtered. The final product emerges from stainless steel tanks, offering a floral aroma of white flowers and rose and an exotic fruits finish. Rosé Piscine can be purchased at select stores around the country and online. To find a store near you or to order online, visit the site.

About Rosé Piscine
A unique wine in that it has been created to be served over ice, Rosé Piscine is taking the nation by storm. Over two million bottles of it have already been sold in France and Brazil, and it is now available in the U.S. Rosé Piscine is pale salmon in color, light to medium in body wine and is made from Négrette, a locally indigenous varietal known for its powerful aromatic qualities. For more information on Rosé Piscine or the company, visit the site.

CBD: An Alternative to Prescription Drugs?

In the modern world, our first approach to treating an illness is to find the most suitable pharmaceutical drug, which we typically get either over-the-counter or on prescription. However, while these medicines are normally effective, they can unlock a whole new box of issues, including dependency and side effects.

Becoming reliant on medication can be mentally unsettling, and nasty side effects like nausea and dizziness typically require further treatment, leaving patients on a cocktail of pharmaceutical-grade drugs before they know it.

In the case of opioid painkillers, dependency may even be life-threatening, with the risk of overdose frighteningly high. In 2016, abuse of prescription opioid painkillers and recreational opiates accounted for more than 40,000 US lives, according to the Centers for Disease Control and Prevention (CDC).

This cycle of illness, drugs, side effects and more drugs is wearing thin with many, and combined with the new wave of medical cannabis science, a clear divide has formed between those who favor prescription drugs, and those who’d rather take natural, plant-based medicines.

From a historical perspective, medicinal cannabis use makes perfect sense, with the herb being used for millennia across the world, but particularly in Africa and Asia.

Technological advancements have greatly developed our knowledge of cannabis, and scientists now know which compounds are responsible for various effects. For example, the psychoactive “high” mostly comes from a therapeutic cannabinoid called tetrahydrocannabinol (THC). However, numerous other cannabinoids have medicinal properties, sans the hallucinogenic effects.

Cannabidiol (CBD) is the most studied and seemingly most useful non-intoxicating cannabinoid, and the market for CBD products has exploded in the 2010s, thanks in part to the relaxation of laws surrounding non-psychoactive hemp.

CBD over opioids
Opioid-based painkillers like Tramadol are now regularly prescribed for chronic pain, with stronger synthetic drugs such as fentanyl available on prescription for the most extreme discomfort. These drugs are designed to interact with opioid receptors in the opioid system. The pain relief from these drugs is substantial, however sustained use leads to increased tolerance, stronger doses and addiction.

However, CBD may be helpful for chronic patients, and also those who have ended up dependent on opioids, as the cannabinoid seems to exhibit anti-addiction properties by interfering with pleasure-reward mechanisms.

By elevating concentrations of anandamide in the body, CBD is promoting a neurotransmitter that works to ease both physical and mental pain. How CBD tackles addiction is less clear, but some evidence indicates that CBD is active in the opioid system.

Not all pain is the same – for example, some chronic pain is persistent and always at a similar intensity, whereas the worst effects of inflammatory and neuropathic pain tend to come from flare-ups.

For internal neuropathic pain, CBD vape oil and e-liquid treatment is ideal, because the relief comes very quickly. Meanwhile, lingering pain is economically and perhaps more efficiently managed by orally-consumed CBD products (e.g. capsules, edibles, coffee).

Experimenting with gels, creams and balms infused with cannabis or CBD is a novel method of coping with localized pain. These ensure that the cannabinoid receptors in the affected area are directly activated.

If you’re unsure where to start searching for the right CBD product and form for your pain or you simply can’t decide with the long list of options, you can click here to learn more.

CBD: the new anti-inflammatory drug?
Immune system response is still not well that understood, and this has made it difficult to control. Researchers have struggled to find ways of influencing inflammation, but studies into the endocannabinoid system have found that immune system response is accessible via cannabinoid receptor 2 (CB2). Endocannabinoids look to signal a stoppage in inflammation, after a wound has fully healed or an infection is neutralized.

This discovery may be crucial, as the current leading class of anti-inflammatories (non-steroidal anti-inflammatory drugs, or NSAIDs) are known to cause concerning side effects, including stomach ulcers.

The best CBD product for inflammation depends, unsurprisingly on the type of inflammation. Internal conditions like irritable bowel syndrome (IBS), which could be exacerbated by endocannabinoid deficiency, respond well to both CBD vape juice and CBD edibles, or even tincture oils.

For osteoarthritis, a form of inflammation which affects the joints, CBD creams and other topicals are likely to produce better results.

CBD’s promise as an antidepressant
Cannabinoid research is providing genuine hope for antidepressant researchers, after decades of stagnation in medication development. The current situation with depression medicine is far from ideal, with selective serotonin reuptake inhibitors (SSRIs) slow to show benefits – for up to 40 percent of patients, these drugs may not even work at all. And then there are the side effects to contend with, which range from drowsiness to impotence. Depersonalization and derealization have also been anecdotally reported with SSRIs.

However, a glut of promising studies on CBD and the brain have found that the ECS could be important in correcting off-balance brain chemistry. The CB1 receptor modulates many variables, mood being one, and the bond between anandamide and this receptor is important for good mental wellbeing. Factors outside of the ECS also affect mood, but the potency of anandamide as an antidepressant makes the link with the CB1 receptor an essential one.

Some of the most exciting research on cannabinoids has been on their neuroprotective and neurogenesis properties. Studies on the hippocampus and the prefrontal cortex and cannabinoid treatments, which are associated with depression, have demonstrated that CBD is able to repair these regions of the brain, by restoring neuronal circuitry and helping to form new brain cells.

A 2018 study on rats carried out in Brazil showed that CBD was effective from the first treatment and for up to seven days after the last dose at blocking synaptic proteins which damage neuronal circuitry in the prefrontal cortex. Meanwhile, CBD-initiated neurogenesis in the hippocampus helps to regrow the brains of adult rats with depression. These results have not yet been replicated in humans, but rats are used for such studies because their brains are similar to humans. General memories and our autobiographical memory are stored in the hippocampus.

The only CBD products that aren’t suitable for managing depression are topicals, as the cannabinoids remain in the skin, and do not reach the brain.